Loading clinical trials...
Loading clinical trials...
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Conditions
Interventions
Lifitegrast
Placebo
Locations
23
United States
SONATA Investigational Site
Artesia, California, United States
SONATA Investigational Site
Hemet, California, United States
SONATA Investigational Site
Laguna Hills, California, United States
SONATA Investigational Site
Lancaster, California, United States
SONATA Investigational Site
Montebello, California, United States
SONATA Investigational Site
Parker, Colorado, United States
Start Date
October 16, 2012
Primary Completion Date
March 3, 2014
Completion Date
March 3, 2014
Last Updated
June 11, 2021
NCT07463950
NCT07363824
NCT07396441
NCT06841471
NCT07268599
NCT06064071
Lead Sponsor
Shire
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions